Marc D Schwartz

Author PubWeight™ 56.51‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 A brief assessment of concerns associated with genetic testing for cancer: the Multidimensional Impact of Cancer Risk Assessment (MICRA) questionnaire. Health Psychol 2002 1.69
2 Short-term impact of cancer prevention and screening activities on quality of life. J Clin Oncol 2004 1.66
3 Intention to undergo colonoscopy screening among relatives of colorectal cancer cases: a theory-based model. Ann Behav Med 2014 1.49
4 Educating African American men about the prostate cancer screening dilemma: a randomized intervention. Cancer Epidemiol Biomarkers Prev 2006 1.48
5 Telephone genetic counseling for high-risk women undergoing BRCA1 and BRCA2 testing: rationale and development of a randomized controlled trial. Genet Test 2008 1.31
6 Development and evaluation of a culturally tailored educational video: changing breast cancer-related behaviors in Chinese women. Health Educ Behav 2007 1.28
7 The influence of culture and cancer worry on colon cancer screening among older Chinese-American women. Ethn Dis 2006 1.25
8 Quality of life after contralateral prophylactic mastectomy in newly diagnosed high-risk breast cancer patients who underwent BRCA1/2 gene testing. J Clin Oncol 2006 1.22
9 The development of a web- and a print-based decision aid for prostate cancer screening. BMC Med Inform Decis Mak 2010 1.21
10 Tolerance for uncertainty and perceived risk among women receiving uninformative BRCA1/2 test results. Am J Med Genet C Semin Med Genet 2006 1.21
11 Predictors and outcomes of contralateral prophylactic mastectomy among breast cancer survivors. Breast Cancer Res Treat 2006 1.20
12 Randomized controlled trial of a psychosocial telephone counseling intervention in BRCA1 and BRCA2 mutation carriers. Cancer Epidemiol Biomarkers Prev 2010 1.19
13 Distress among women receiving uninformative BRCA1/2 results: 12-month outcomes. Psychooncology 2009 1.17
14 Disparities in cervical cancer screening between Asian American and Non-Hispanic white women. Cancer Epidemiol Biomarkers Prev 2008 1.16
15 Information needs of mothers regarding communicating BRCA1/2 cancer genetic test results to their children. Genet Test 2007 1.16
16 Brief assessment of parents' attitudes toward testing minor children for hereditary breast/ovarian cancer genes: development and validation of the Pediatric BRCA1/2 Testing Attitudes Scale (P-TAS). J Pediatr Psychol 2008 1.12
17 Developing and validating a measure of Chinese cultural views of health and cancer. Health Educ Behav 2007 1.08
18 Knowledge, cultural, and attitudinal barriers to mammography screening among nonadherent immigrant Chinese women: ever versus never screened status. Cancer 2009 1.08
19 Long-term psychosocial outcomes of BRCA1/BRCA2 testing: differences across affected status and risk-reducing surgery choice. Cancer Epidemiol Biomarkers Prev 2012 1.08
20 Longitudinal changes in patient distress following interactive decision aid use among BRCA1/2 carriers: a randomized trial. Med Decis Making 2010 1.03
21 Perceived risk of breast cancer among Latinas attending community clinics: risk comprehension and relationship with mammography adherence. Cancer Causes Control 2008 0.99
22 Tamoxifen as chemoprevention in BRCA1 and BRCA2 mutation carriers with breast cancer: a pilot survey of physicians. J Clin Oncol 2003 0.99
23 Utilization of breast cancer screening in a clinically based sample of women after BRCA1/2 testing. Cancer Epidemiol Biomarkers Prev 2002 0.99
24 Enhancing informed choice to undergo health screening: a systematic review. Am J Health Behav 2013 0.98
25 Predictors of cognitive appraisals following genetic testing for BRCA1 and BRCA2 mutations. J Behav Med 2004 0.96
26 Development of an Interactive Decision Aid for Female BRCA1/BRCA2 Carriers. J Genet Couns 2003 0.96
27 Results of a randomized controlled trial testing the efficacy of a culturally targeted and a generic video on mammography screening among chinese-american immigrants. Cancer Epidemiol Biomarkers Prev 2012 0.95
28 Cognitive and emotional factors predicting decisional conflict among high-risk breast cancer survivors who receive uninformative BRCA1/2 results. Health Psychol 2009 0.95
29 Motivation-based intervention to promote colonoscopy screening: an integration of a fear management model and motivational interviewing. J Health Psychol 2011 0.94
30 Conveying genomic recurrence risk estimates to patients with early-stage breast cancer: oncologist perspectives. Psychooncology 2013 0.92
31 BRCA1/2 test results impact risk management attitudes, intentions, and uptake. Breast Cancer Res Treat 2010 0.92
32 Telehealth personalized cancer risk communication to motivate colonoscopy in relatives of patients with colorectal cancer: the family CARE Randomized controlled trial. J Clin Oncol 2014 0.92
33 Prostate cancer screening and shared decision-making preferences among African-American members of the Prince Hall Masons. Psychooncology 2008 0.91
34 BRCA1/2 genetic testing uptake and psychosocial outcomes in men. Fam Cancer 2011 0.91
35 Examining the challenges of family recruitment to behavioral intervention trials: factors associated with participation and enrollment in a multi-state colonoscopy intervention trial. Trials 2013 0.90
36 Practical aspects of delivering hereditary cancer risk counseling. Semin Oncol 2007 0.90
37 Fostering informed decisions: a randomized controlled trial assessing the impact of a decision aid among men registered to undergo mass screening for prostate cancer. Patient Educ Couns 2013 0.90
38 The influence of acculturation and breast cancer-specific distress on perceived barriers to genetic testing for breast cancer among women of African descent. Psychooncology 2009 0.90
39 Receipt of genetic counseling recommendations among black women at high risk for BRCA mutations. Genet Test Mol Biomarkers 2012 0.89
40 "Is it really worth it to get tested?": primary care patients' impressions of predictive SNP testing for colon cancer. J Genet Couns 2012 0.87
41 Translational Genomic Research: Protocol Development and Initial Outcomes following SNP Testing for Colon Cancer Risk. Transl Behav Med 2012 0.86
42 Intervention tailoring for Chinese American women: comparing the effects of two videos on knowledge, attitudes and intentions to obtain a mammogram. Health Educ Res 2012 0.84
43 Contralateral prophylactic mastectomy: efficacy, satisfaction, and regret. J Clin Oncol 2005 0.84
44 Changes in diet and physical activity following BRCA1/2 testing. J Psychosoc Oncol 2008 0.84
45 The impact of item order on ratings of cancer risk perception. Cancer Epidemiol Biomarkers Prev 2002 0.84
46 Association of Rad51 polymorphism with DNA repair in BRCA1 mutation carriers and sporadic breast cancer risk. BMC Cancer 2011 0.83
47 Factors associated with psychological distress among women of African descent at high risk for BRCA mutations. J Genet Couns 2012 0.83
48 Psychosocial and Quality of Life in Women Receiving the 21-Gene Recurrence Score Assay: The Impact of Decision Style in Women with Intermediate RS. J Cancer Epidemiol 2012 0.81
49 Mutagen sensitivity, tobacco smoking and breast cancer risk: a case-control study. Carcinogenesis 2010 0.81
50 Behavioral and psychosocial responses to genomic testing for colorectal cancer risk. Genomics 2013 0.80
51 Use and evaluation of a CD-ROM-based decision aid for prostate cancer treatment decisions. Behav Med 2010 0.79
52 Intentions for bilateral mastectomy among newly diagnosed breast cancer patients. J Surg Oncol 2012 0.77
53 Predictors of enrollment into a familial cancer registry by individuals at high risk for BRCA1/2. Cancer Epidemiol Biomarkers Prev 2007 0.77
54 American BRCA Outcomes and Utilization of Testing (ABOUT) study: a pragmatic research model that incorporates personalized medicine/patient-centered outcomes in a real world setting. J Genet Couns 2014 0.77
55 Intentions for risk-reducing surgery among high-risk women referred for BRCA1/BRCA2 genetic counseling. Psychooncology 2014 0.77
56 Oophorectomy in carriers of BRCA mutations. N Engl J Med 2002 0.75
57 Baseline Attitudes About Prostate Cancer Screening Moderate the Impact of Decision Aids on Screening Rates. Ann Behav Med 2015 0.75